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Summary
To assess the role ofdifferent types of antigen-presenting cells(APC) in the induction of tolerance,
we isolatedB cells, macrophages, and dendritic cells from thymus and spleen, and injected these
into neonatal BALB/c mice across an Mls-1 antigenic barrier. One week after injection ofAPC
from Mls-I-incompatible mice or from control syngeneic mice, we measured thenumber of thymic,
Mls-1'-reactive, Vs6+ T cells and the capacity of thymocytes to induce a graft-vs.-host (GVH)
reaction in popliteal lymph nodes of Mls-1' mice. Injection of thymic but not spleen B cells
deleted thymic, Mls-1'-reactive Vs6+ T cells and induced tolerance in the GVH assay. The
thymic B cells were primarily of the CD5+ type, and fluorescence-activated cell sorter-purified
CD5+ thymic B cells were active. Injection of dendritic cells from spleen or thymus also induced
tolerance, but the Vs6 cells were anergized rather than deleted . Macrophages from thymus did
not induce tolerance. Dendritic cells and thymic B cells were also effective in inducing tolerance
even when injected into Mls - , major histocompatability complex-incompatible, I-E - mice, but
only thymic B cells depleted V06-expressing T cells . Therefore, different types ofbone marrow-
derived APC have different capacities for inducing tolerance, and the active cell types (dendritic
cells and CD5+ thymic B cells) can act by distinct mechanisms .
O
ne of the important functions of the thymus gland is
to inactivate lymphocytes that would react against self-
constituents (1) . Tolerance can develop in at least two ways :
clonal deletion (2-5) and clonal anergy (6-8) . The latter refers
to a phenomenon whereby self-reactive T cells are present
but are unable to make an effective response to antigen. T
cells expressing both x/,6 andy/S types ofTCR can be toler-
ized in the thymus (9-13). There is evidence that thymicAPC
derived from the bone marrow are somehow important in
bringing about tolerance (12, 14), one such model being the
induction of tolerance to an antigen called Mls (15) . Mls is
an attractive model since specific TCR Vs genes encode re-
activity to specific alleles of Mls, enabling one to enumerate
Mls-reactive T cells (3, 5) .
We have noted that the mouse thymus contains a small
number ofB cells, the majority of which express the CD5
molecules (16) . B cells are known to be the major type of
APC that express MIS (17-19) . We havenow prepared highly
enriched populations ofB cells from thymus and spleen and
injected these into the thymi of mice at the neonatal period,
when mice are most susceptible to the induction oftolerance
(20-22) . We find that B cells from thymus, including those
bearing CD5, and activatedB blasts, but not resting spleen
B cells, can induce tolerance by deleting Mls-reactive T cells .
When other APC are tested, dendritic cells but not macro-
phages also can tolerize to Mls, but the dendritic cells do
so by inducing clonal anergy rather than deletion.
Materials and Methods
Mice.
￿
Mice with different MIS and MHC antigens were ob-
tained from Japan SLC ; Shizuoka and Clea Japan ; Osaka, Japan .
The strains were DBA/2,H-2d, Mls-1'; BALB/c, H-2d, Mls-16 ;
BALB/c x DBA/2 F, (CxD2 F,), H-2d, Mls-lbia; C57BL/6,
H-2b, Mls-1b, C57BL/6 x DBA/2 (B6xD2 F,) H-2b/d, Mls-11/2 ;
BALB/c x C57BL/6 (CxB6 F,), H-2d/b, Mls-1b ; C3H/He, H-2t,
Mls-I" ; B6.H-2t, H-2t, Mls-l"; and AKR/J, H-2E, Mls-1' .
APC.
￿
Dendritic cells and thymic B cells were prepared as de-
scribed elsewhere (16, 23) . These APC were >98% Ig- and
>95% Ig', respectively, and lacked detectable macrophages
stained with F4/80mAb. Briefly, dendritic cells were prepared from
collagenase-digested organs that were centrifuged in dense BSA
columns to provide low-density adherent populations. After over-
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phages remained adherent but could be dislodged after 30 min of
culture in PBSwith 1mM EDTA at 37°C. In some experiments,
dendritic cells were further purifiedby treatment with anti-B cell
mAb(RA3-3A1/6.1;TIB146 orJ11d.2;TIB183) plus rabbit comple-
ment. Depletion ofB cellswasmonitoredby the absence ofmitogen
responses to LPS . Positive selection of dendritic cells wasperformed
by sorting as N418' (24) cells using a FACStar Plus* (Becton
Dickinson& Co., Mountain View, CA) according to method de-
scribed (25) . Thymic B cells were prepared from teased thymi that
werecentrifuged in dense Percoll columns to provide alow-density
population . The low-density fraction from the teased thymi had
only trace levels of dendritic cells, and was depleted ofT cells by
treatmentwith amixture ofantiThy-1.2 (HO-13-4), CD4(GK1.5),
and CD8 (HO-2.2 and3.155) mAb and complement . Anti-CD5
mAb (C3PO ; American Type Culture Collection, Rockville, MD)
was used to deplete CD5' B cells (N75% of the total) in the
thymicB cell population, while biotinylated anti-CD5 and PE-avidin
(Becton Dickinson &Co .) were used to sort the CD5' B cells
on a FACStar instrument (Becton Dickinson & Co.) . Splenic B
cells were Sephadex G-10 nonadherent cells depleted ofT cells by
antiThy-1.2mAb andcomplement, followedby Percoll density gra-
dient centrifugation to obtain high-density resting B cells . Splenic
B cells cultured for 24 h with goat F(ab')2 anti-mouse IgM Ab
(Tago Inc., Burlingame, CA) plus murine IL-4 served as Bblasts .
Neonatal Tolerance Regimen to Mis, and Frequency of Mls-reactive
TCells . BALB/c Mls-lb newbornmice within 24 hof birth were
anesthetized with diethyl etherand fixed onto aboardwith rubber
bands. The mediastinum was opened and 0.5 pl of an APC cell
suspension (5 x 105 ) was injected directly into each lobe of the
thymus usinga 5-pl microsyringe. TheAPCwere from incompat-
ible Mls-1' or from syngeneic Mls-lb mice . The chest was then
closed by suturing the overlaying skin. 1 wk later, the thymus or
pooled peripheral lymph nodes (axillary, inguinal, brachial, mesen-
teric) were removed and tested for Mls reactivity (below) or for
the frequency of cells expressing different TCR Vs antigens by
FACScan andConsort30 program(BectonDickinson&Co.) .The
antiV06 and antiVs8 mAbs were rat 44-22-1 and mouse F23.1,
respectively, and these were visualized with FITC mouse anti-rat
Ig (Boehringer Mannheim Biochemicals, Indianapolis, IN) andgoat
anti-mouse Ig (Cappel Laboratories, Malvern, PA). As will be evi-
dent in the results, antiVs6 cells were tolerized while most Vs8
cells were not, even though some V,s8 .1 cells are Mls-1' reactive (3) .
Responses to Mls In Viva
￿
Different APC, including CD5' B
cells enriched by sorting thymicB cellson aFACStar after staining
with biotinylated anti-CD5 plus PE-avidinmAb (26), were injected
intrathymically into BALB/c neonatal mice. 1 wk later, reactivity
of these tolerized cells to Mls-1' in vivo was assessed by injecting
2 x 10' thymocytes in 25 td into the hind footpad of adult mice
that were disparate at Mls-1' or MHCloci or at both loci . Lymph
node swelling as a measure of a local graft-vs .-host reaction
(GVHR)' was performed 7 d later (27) . Percent responsiveness was
calculated according to the formula: 100x ((lymph node weight
in experimental mouse - themean weight in negative control)/(the
mean weight in positive control - the mean weight in negative
control)] . The positive controls were given thymocytes from BALB/c
mice and the negative controls were given thymocytes from age-
matched syngeneicCxD2 mice . This assay maymeasure tolerance
to Mls' as well as tolerance to other histocompatibility differences
between BALB/c and DBA/2.
'Abbreviation used in this paper : GVHR, graft-vs.-host reaction .
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Responses to Mls In Vitro.
￿
Expression of Mla-1' by APC was
evaluated with aMLR in vitro. CD4+ T cells from BALB/c or
CxB6 mice or from control CxD2 mice were prepared by passing
a mixture of spleen and lymph node suspensions over nylonwool
columns and then depleting CD8+ cells with anti-CDS mAb plus
rabbit complement . The stimulators were from Mls-1' CxD2 or
B6xD2mice or MHC-incompatible B6.H-2tmice. TheAPC were
treated with 40 Fig/ml ofmitomycin C for30min at 37°Cbefore
responder T cells, 3 x 105 per flat-bottomed microtest well, were
added . The culture medium was 0.2 ml ofRPMI 1640 containing
10% FCS, 50p.M 2-ME, and 100 Ag/ml gentamicin . DNA syn-
thesis was determined as ['H]thymidine incorporation (1 uCi/ml,
6 Ci/mM) at 72-84h. Results are themean of triplicate cultures .
The frequency of responding T cells expressing V,96 or Vs8 was
assessed at day3usingFACS analyses (above) ofthe smalland large
cell fractions, as distinguished by forward light scattering and as
illustrated in Results.
Responsiveness to immobilized anti-V#6, antiVg8 and anti-
CD3mAbwasmeasured by proliferation ofBcell-depletedlymph
node cells (axillary, brachial, and mesenteric nodes) obtained from
mice that were injected intrathymicallywith APC9 d before . The
anti-V06, anti-V08, and anti-CD3 mAbs in culture supernatant
were fixed onto tissue culture plates by 50,ug/ml of goat anti-rat
IgG, anti-mouse IgG, andanti-hamster IgG, respectively. Results
are the means of duplicate cultures.
Results
Presentation ofMls Antigens by Thymic B Cells and Other
APC. We first compared the capacity of CD5+ BAs and
dendritic cells from the thymus to present Mls alloantigens
to T cells in vitro, since this had not been studied previously.
CD4+ T cells were used as responders, since the bulk of the
E a
U
0
0
c
i
101 -
Z
c
0
o to
a
to'
A
Distinct Mechanisms of Tolerance from Different Antigen-presenting Cells
e
HAmber of APC
Figure 1.
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Stimulatory activity ofdendritic cells and thymicBcellsduring
the in vitro response to Mls-1' . The T cells were CD4' cells from
BALB/c mice (A). The APC were dendritic cells from thymus (O, ")
and spleen (A, A), bulk thymicB cells(0, +), thymic B cells depleted
ofCD5* cells ( I ), B blasts (E], /), and resting splenic B cells (0, V)
from incompatible CxD2 F, (H-2d, Mls-1") (open symbols) andBALB/c
(H-2d, Mls-1b) (closed symbols) . Responses of CD4' T cells from MHC-
incompatible C57BL/6 mice (H-2b, MLS-1') served as positive controls
for the BALB/c APC (B) .CD4 " T cells were stimulated with different preparations of dendritic cells. Cultured denditic cells were cells that became nonadherent after over-
night culture of low-density adherent cells . These were further purified by rosetting with antibody-coated sheep erythrocytes (FcR-), by the treat-
ment with mAb (RA3-3A1 anti-B220a or Jlld anti-heat-stable antigen) plus complement, or by sorting with FACStar plus as N418' cells from
cultured dendritic cells or from freshly prepared cell suspensions (25) . The purity of the dendritic cell preparations in Exp . 1 was monitoredby LPS-
induced proliferation . The values of [3H]thymidine incorporation between 58 and 70 h culture at 2 x 105 cells/well with 20 jug/ml LPS were 4,800
cpm, in cultured cells . 1,018 cpm in FcR- , 206 cpm in 146- , and 248 cpm inJIM- of BALB/c dendritic cells, and 5,219, 1,197, 309, and 276
cpm . in CxD2 dendritic cells, respectively . Spleen cells under the same culture condition incorporated [3H]thymidine of 184,950 cpm. T cell polifer-
ation was monitored by [3H]thymidine incorporation between 72 and 84 h of culture. Each number represents the mean of triplicate cultures .
' Dose of APC.
response to Mls is mediated by this subset (28) . Thymic B
cellsproved to be strong stimulators ofan anti-Mls response
(Fig. 1 A [0]), whereas resting splenicB cells were weak
(Fig. 1 A [p]), as reported (18) . Mls-1'-bearing, CxD2 Ft
thymic B cells were at least 100 times more potent in stim-
ulating BALB/cT cells than syngeneic CxD2 B cells (Fig .
1 A [compare 0 and *]). The activity of the thymic B
cell preparation was reduced by >90% by treatment with
anti-CD5 mAb andcomplement (Fig. 1A [0 vs. I]) . Splenic
B cells had to be activatedby anti-Ig to become strongAPC
for Mls antigens (Fig . 1 A [0]), again as reported (18) . In
contrast to previous results, however, it appeared that thymic
and spleen dendritic cells couldpresent Mls antigens. Speci-
fically, we found thatTcells proliferated more activelywhen
there was an Mls disparity expressed by the dendritic cell
(CxD2-stimulatingBALB/c) than when there was no such
disparity (BALB/c-stimulating BALB/c) (Fig. 1A [O vs .
551
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Table 2 . Selective Stimulation of V,B6' T Cells by Mb-i°
Frequency of Vp6- and V,98-bearing small and large cells, as distin-
guished by forward light scatter (Fig. 2), in BALB/c CD4* T cells that
were unstimulated or stimulated with MHC- vs . Mls-incompatible den-
dritic cells (Fig . 2) .
Table 1 . Stimulatory Activity ofPurified Dendritic Cells to Mls-disparate T Cells
Dendritic cells T cell proliferation
Exp. T cells from : Strain Organ Purification 3 x 104* 10 4 3 x 103 10,
x 10 -1 cpm
1 Syngeneic BALB/c Spleen Cultured 11 .5 9.1 4.9 1.8
(BALB/c) Cultured FcR- 10.3 9.6 4.5 1.2
Cultured 146 - 12.4 10.7 4.1 0.8
Cultured J11d- 9.8 7.9 2.9 0.4
Mls-incompatible CxD2 Spleen Cultured 84.4 51.6 32.5 13.2
(BALB/c) Cultured FcR- 85 .3 53.2 31.9 14.1
Cultured 146 - 89.6 59.3 32.8 10.5
Cultured J11d- 87.5 52.5 28.5 11.0
2 MHC-incompatible B6xD2 Spleen Cultured FcR- 159.1 99.1 33.8
(CxD2) Cultured N418' 174.7 80.8 20.8
Fresh N418' 109.7 45.1 12.8
Thymus Cultured FcR- 218.2 163.4 91.4
Cultured N418' 229.3 157.7 68.4
Fresh N418' 136.3 43.0 10.8
Mls-incompatible B6xD2 Spleen Cultured FcR- 181.2 74.6 20.6
(CxB6) Cultured N418' 186.3 69.7 17.3
Fresh N418' 170.7 43.0 10.8
Thymus Cultured FcR- 134.7 52.7 12.6
Cultured N418' 117.7 35.1 7.2
Fresh N418' 38.7 7.2 2.1
Large cells Small cells
Stimulus Exp. V,98' Vs6+ Vs8' Vs6'
%
MHC 1 20.0 13.6 16.5 12.3
Mls 1 25.8 55.9 9.2 10.2
2 26.5 55.3 19.8 9.8
None 1 ND ND 19.0 13.3Figure 2 .
￿
Frequency of Vs8+ and V06+ T cells during the response
of BALB/c T cells to dendritic cells from Mls-incompatible, MHC-
compatibleBALB/c x DBA/2 or MHC-incompatible B6.H-2k mice. After
3 dofcultureinwhich 30,000dendritic cells were used to stimulate 300,000
CD4+ T cells, the cultures were harvested and stained with rat mAb fol-
lowed by FITC mouse anti-rat Ig. The rat mAb are listed at the top and
include a nonreactive control (RB6 antigranulocyte), anti-CD4 (GK1 .5),
antiVp8 (KJ16), and antiVo6 (44-22-1). Dead cells and debris were gated
out on the basis ofpropidium iodide-staining and low forward light scatter .
Shown here are the data on live cells comparing fluorescence (y-axis, four
decates) and forward light scatter (x-axis) as a measure of cell size. The
arrows denote the location of small unstimulated lymphocytes, while to
the right of the arrow are found the enlarged blasts. To show that the
blasts were responding to dendritic cells, the cultures were separated into
cluster andnoncluster fractions, since most ofthedendritic cells and blasts
are found in large aggregates as described (44) . Note that most of the
large blasts are found in the cluster fraction when either Mls or MHC
is the stimulus (e.g., open arrow) . However, in the case of Mls, the majority
of the blasts express the Mls-1-reactive TCR, V06, whereas in the case
ofMHC, the frequency of V06 blasts is low and comparable with un-
stimulated T cells (latter not shown) .
and A vs . " ]) . APC from both CxD2 and BALB/c mice
actively stimulated CD4+ T cells from MHC-incompatible
C57BL/6 mice (Fig . 1 B) .
It is possible that the proliferation ofT cells that was in-
duced by dendritic cells was due to a small contamination
of Ig+ B cells in the dendritic cell population . However, B
cell-depleted purified dendritic cell preparations were com-
parably effective in stimulating Mls-disparate T cells to con-
ventional FcR- dendritic cell preparation (Table 1, Exp. 1) .
Vp6 Vpe
6.8% 4.7%
Fluorescence intensity
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Figure 3.
￿
Deletion of Vs64 T cells in BALB/c mice by intrathymic
injection of thymic B cells, but not splenic dendritic cells . Thymus cell
suspensions from BALB/c newborn mice were stained with antiVp6 mAb
and FITC-conjugated anti-rat Ig Ab (A-E) or anti-V,98 mAb and FITC-
conjugated anti-mouse Ig Ab (EJ) 7 d after injection with CxD2 thymic
B cells (B and G), thymic dendritic cells (C and M, high density spleen
B cells (D and 1), or splenic dendritic cells (E andJ) . V06 and V08 ex-
pression in thymocytesfrom BALB/c newborn mice without injection are
shown as controls (A and F) and are similar to results obtained after injec-
tion of syngeneic BALB/c APC (Fig . 4 A) . Dead cells were gated out
by the staining with ethidium bromide.
In addition, positively selected cultured N418+ (CD11c+)
dendritic cells (25) from the spleen and the thymus were also
a potent stimulator for Mls-disparate CD4+ T cells (Table
1, Exp. 2) . Fresh N418+ spleen dendritic cells appeared to
be slightly less active than cultured cells as described for stim-
ulation of the primary MLR (25) . This was more evident
in thymic dendritic cells .A
Uninjected
CD2F 1 Spl DC
CD2F1 Sol B cells
CD2F 1 Thy B cells
CD2F 1 Thy CD5' B cells
CD2F, Thy CD5 - B cells
BALBlc Sol B cells
BALBlc Thy B cells
B
Uninfected
Syngeneic Spl
CD2F, Sol DC 2.5x10'
5x105
C
to"
CD2F, Th y DC 5x105
CD2F, Thy MO 5x105
Uninjected
Syngeneic Spl
CD2F, bulk Spl B
CD2F 1 high density Spl B
CD2F, B blasts
CD2F, Spl DC
CD2F 1 Sol MO
Figure 4.
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In vivo reactivity to Mls-1a
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antigen of thymocytes from mice in-
jected with various APC . Neonatal
BALB/c mice were given intrathymic
injections of5 x 105 APC (A and C),
or the indicated numbers of dendritic
cells from spleen or thymus (B) . Re-
sponsiveness of the thymocytes to
Mls-1a antigen (CxD2, filled citrles) and
MHC antigen (OH, open curies) at 1
wk after injection was measured by
lymph node swelling in local GVHR .
Results are shown as the mean of per-
cent responses (open bar and short ver-
tical line) relative to that induced by
thymocytes from age-matched unin-
jected BALB/c newborn mice. Each
circle represents the response of an in-
dividual mouse . The values of lymph
node weight in six mice as'positive and
negative controls (see Materials and
Methods) in anti-Mls responseandanti-
MHC response were 3.02 ± 0.26 and
°
￿
1.09 ± 0.22 mg, and 3.43 t 0.29 and
1.18 ± 0.20mg in Exp.A ; 3.23 ± 0.26
and 1.02 ± 0.11 mg, and 3.55 t 0.32
and 1.22 ± 0.19mg in Exp. B ; and3.20
± 0.31 and 0.99 ± 0.13 mg, and 3.68
± 0.29 and 1.19 ± 0.16 mg in Exp.
C, respectively. The response to Mls and
MHC antigens in mice injected with
medium alone was 1.03 ± 0.24 and 1.11
± 0.08 mg in A, 0.97 ± 0.12 and 1.13
± 0.15 mg in B, and 0.96 ± 0.11 and
1.14 ± 0.15mg in C, so that the differ-
ences between medium control and the
negative injection control were in-
significant . A part of the thymocytes
from each mouse was stained with anti-
Vs6 mAb (44-22-1) plus FITC anti-
rat Ig or antiV~ 8 (F23 .1) plus FITC
anti-mouseIg for FACS analysis. Values
are the sum of percentage of Vo6hlsh
50
￿
100
￿
130
￿
and Vs61°w T cells, and results repre-
sent the mean values with SD. Expres-
GVH response (%)
￿
sion ofV08 was not determined in A,
but the percent positive cells of Vs6
and Vo8 in separate experiments were 5.9 ± 0 .1 and 11.6 ± 0.5 in uninjected BALB/c, 0 .7 ± 0 .4 and 11.3± 0.3 in mice injected with CxD2 thymic
B cells, 3.0 ± 0.4 and 11.3 ± 0.3 in mice injected with CxD2 CD5- thymic B cells, and 5 .8 ± 0 .1 and 11.3 ± 0.2 in mice injected with CxD2
splenic dendritic cells.
5.6 t 0.5
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That the stimulating antigens on dendritic cells were in
fact Mls was also evidenced by the finding that -55% of
the enlarged T blasts induced by Mls-disparate CxD2 den-
dritic cells expressed the Vj36 gene that confers Mls reac-
tivity, whereas only -13% of the blasts were positive after
stimulation with MHC-incompatible dendritic cells (Fig. 2
and Table 2) . Therefore, stimulation with Mls selectively ex-
pands T cells expressing V06, while stimulation withMHC
does not expand thesecells above their normal frequency. Only
a slight increase in the frequency of V08+ blasts was ob-
served after stimulation by Mls-disparate dendritic cells rela-
tive to allogenic dendritic cells (Table 2) . This result sug-
gests. that V06+ T cells are the major cell type responding
to Mls-1' antigen, although some V08.1, 7, and 9 T cells
6.2 t 1 .0
5.6 t 1 .0
5.8 t 1.0
6.8 t 0 .7
5.5 t 0 .5
5.5 t 0.5
6 .6 t 0.5
6.1 t 0.5
4 .2 t 0.5
5.7 t 0.4
0 .9 t 0 .5
6 .5 t 0.6
6 .5 t 0.4
X positive cells
5.9 t 0.5
5.5 t 0.5
4 .3 t 0.6
1 .8 t 0.4
0.7 t 0.2
3.0 t 0.1
5 .6 t 0.4
5.5 t 0.5
N.T.
12.7 t 0.4
12.3 t 1 .0
11.7 t 0.7
12.6 t 1.3
12.3 t 0.7
13.7 t 1 .4
12.1 ± 0 .4
12.7 t 0 .6
12.4 t 1 .1
11 .3 t 1 .7
12 .5 t 0.7
11 .2 t 0 .6
12.7 t 1 .3
12.5 t 0.8
can also be reactive from work in other laboratories . Similar
results were obtained in Mls-MLR using thymic dendritic
cells, thymic B cells, and splenicB blasts. We therefore con-
clude that thymic B cells, splenic B blasts, and both thymic
and spleen dendritic cells can carry Mls antigens in a stimula-
tory form .
ThymicB Cells Induce Neonatal Tolerance by a Deletional Mech-
anism . We proceeded to inoculate both lobes of neonatal
thymi with populations of thymic and splenic B cells and
dendritic cells. The injected APC were from CxD2 F 1 mice
(Mls-1'), or from syngeneic BALB/c as controls, and the
neonates were 0-1-d-old BALB/c [Mls-16], so that we could
monitor the frequency of V#6-bearing T cells that
responded to-Mls-12 . We evaluated the thymi at day 7 whenLymph node cells from axillary, inguinal, brachial and mesenteric nodes were obtained from individual mice and depleted of B cells by the treatment
with mAb (TIB146 ; anti-B220) plus complement . Responsiveness to immobilized anti-Vp6, anti-VO8, and anti-CD3 was assessed in vitro . Prolifer-
ation was measured by [3H]TdR incorporation of 3 x 105 cells at 68-72 h for anti-V06 and anti-V,98 mAbs and at 34-48 h for anti-CD3 mAb .
Results represent the mean of duplicate cultures . V06 expression of T cells was also monitored by FACScan, as described in Fig . 2 .
control BALB/c thymocytes included 5.6% V061°"' and
1.3% Vo6h'gh T cells (Fig. 3 A) . When the BALB/c thymi
had been injected withCxD2 thymic B cells, however, there
was virtually a complete deletion of both V06h'gh and V061°"'
(Fig . 3 B) . Moreover, the intrathymic injection of BALB/c
thymic B cells did not affect the V#6 expression of thymo-
cytes (not shown) . Injections of resting B cells from spleen,
and dendritic cells from spleen or thymus, did not delete
thymocytes expressing Vs6 (Fig . 3, C-E) . Therefore, thymic
CD5+ B cells can delete self-reactive T cells in neonatal
thymi, but dendritic cells cannot .
To pursue tolerance at the functional level, we relied on
an in vivo approach . An in vitro assay was not used, since
it is difficult to induce a significant proliferative response
to Mls-1' in thymocytes. This is presumably because the
number of CD4+, V,66+ cells is so small . However, it is
known that thymocytes can induce an anti-Mls response in
vivo in the form of a local GVHR, in which T cells injected
into the footpad lead to the enlargement of the draining
popliteal lymph node (27) . The thymocytes from newborn
BALB/c mice given intrathymic inoculation ofCxD2 Mls-
incompatibleAPC were therefore injected into the footpads
ofCxD2 mice to examine the reactivity to Mls. As expected,
when bulk thymic B cells or purified CD5+ thymic B cells
had been injected into the thymi, the thymocytes lacked Mls-
1'-reactive cells and did not induce GVH (Fig. 4 A) . How-
ever, no change of reactivity to third-party allogenic MHC
antigen was observed . Treatment of thymicB cells with anti-
CD5 mAb and complement depleted some but not all of the
tolerizing activity. This may indicate a role for CD5 -
thymic cells, or a lack of complete killing of the active
CD5+ component . If bulk populations of splenic B cell
were injected, the change of Vs6 expression and reactivity
to Mls-la was slight (Fig. 4, A and C) . High-density resting
spleen B cells induced neither a change of V06 expression
nor tolerance to the Mls product (Fig. 4 C) . Like thymic
B cells, however, activated spleen B blasts deleted V#6-
expressing thymocytes, resulting in a lack ofreactivity to Mls
(Fig. 4 C) .
N
N U
N 0 a
5
Age of mice
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Figure 5 . V06-expressing cells and CD5+ B cells in the thymus of
CxD2 mouse during the early postnatal period. Expression of Vs6 in
thymocytes and the appearance ofCD5+ B cells in the thymus were moni-
tored by FACS. Values from each mouse are shown for Vs6+ cells (" )
and CD5+ B cells (A) . The percent VO6-expressing T cells in peripheral
blood of theCxD2 mouse (0) was also determined using pooled blood
from six mice. Adult BALB/c mice (O) were used as a positive control.
Note that in the Fig. 3 legend, it was shown that at day 7, V06-expressing
cells in the 7-d-oldCxD2 mouse were inactive in inducing localGVHR .
Table 3 . Anergy ofT
Treatment of mice
Cells after Injection
Mouse
no .
of Mls-incompatible
Percent
V06+ cells
Dendritic Cells
Response
No mAb
[3H]TdR uptake to stimulation
Anti-Vs6 Anti-V#8
with :
Anti-CD3
x 10-3 cpm
None 1 5.8 960 7,615 11,189 53,600
2 6.9 1,012 8,414 12,269 49,658
3 6.1 1,050 7,958 13,570 55,108
CxD2 Thymic B cells 4 0.1 860 1,112 10,236 51,000
5 0.3 1,100 1,324 11,193 53,326
6 0.2 970 1,208 11,869 45,826
CxD2 Dendritic cells 7 5.2 1,005 2,218 12,186 50,169
8 6.0 963 2,516 11,092 47,819
9 5.7 1,181 2,318 10,816 51,219Table 4. Direct Effect of M&1°-expressing Thymic B Cells on the Deletion of V#6* T Cells in the Thymus
Local GVH reaction from thymocytes
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Exp . Strain
Newborn mouse
Injected with :
Donor Cell type No .
BALB/c
H-2a
Mls-16
injected
CxD2
H-2a
Mls-1'
into :
B6xD2
H-2bia
Mls-1'
AKR
H-2t
Mls-1'
Surface
expression in
lymph nodes of.,
V#6 V#8
1 C57BL/6 B6xD2 Thymic B 1 4.6 14 .1 17 .0 98 .1 1.2 18 .9
2 8.1 14.8 19 .8 105.6 0.9 17.7
3 11.0 6 .8 15 .2 120.0 1.4 18.8
4 4.9 9.9 2.3 95.4 1 .5 18.4
Dendritic cell 1 1 .2 5 .2 1 .7 90.5 11.5 19.9
2 4 .9 13.0 2.3 106.7 12.2 18.9
3 4.9 11 .7 6.8 110.0 11 .0 19.5
4 11 .8 19.5 15.7 106.7 13 .7 19.1
CxB6 Thymic B 1 15.9 21.0 25.8 101.2 11 .2 19.8
2 2.1 15.9 29.8 110.0 11 .4 18.1
3 4.9 17.9 30.4 98.9 12.7 14.0
4 17.5 34.1 49.3 102.5 11 .0 17.5
Dendritic cell 1 11 .3 11.1 11.1 102.2 11 .9 19.3
2 21 .0 20.5 21.5 120.0 12.8 20.7
3 1 .6 2.3 5.8 111.1 12.1 18.3
4 14.3 18.9 15.8 97.4 11 .0 19.8
Surface
expression in
thymocytes of.
2 (A) C57BL/6 CxD2 B6xD2 OH V06 V08
BALB/c B6xD2 Thymic B 1 10.7 8.5 14.7 99 .1 0.8 8.2
2 8.7 5 .9 11 .0 102.0 0.6 10.2
3 12 .9 10.0 12.6 112.7 1 .1 8.0
4 7.5 9.6 14.5 89.9 0.9 9.7
Dendritic cell 1 10.8 18 .1 12.9 89.2 7 .9 8.2
2 5.7 10.5 8.2 117.9 7.9 8.5
3 12 .6 20.3 9.6 98.6 6 .5 9.5
4 19.5 33.1 12.6 117.4 6.8 8.7
(B) BALB/c B6xD2 OH
C57BL/6 B6xD2 Thymic B 1 15.0 17.0 121.9 0.8 9.2
2 13.1 14.8 115.6 1.0 12.3
3 18.7 20.1 106.5 1 .3 11.5
4 9.0 5.7 87.9 1 .1 10.7
5 5.4 4.8 97.2 0.7 11.9
6 19.0 19.8 120.8 1 .2 10.7
(continued)Table 4 . (continued)
Newborn mouse
Injected with:
Strain
￿
Donor
￿
Cell type
Dendritic Cells Induce Neonatal Tolerance to Mls via Clonal
Anergy . As shown above, splenic dendritic cells did not in-
duce clonal deletion in neonatal mice, but surprisingly, these
APC did induce functional tolerance. No local GVHR was
observed usingT cells from thymi that had been injectedwith
dendritic cells, in spite of the presence of cells expressing
Vs 6 (Fig. 4 B) . This indicates that dendritic cells can induce
tolerance, but the mechanism is likely to be clonal inactiva-
tion rather than deletion .
To verify that the Va6+ cells in dendritic cell-tolerated
mice are anergic, we tested their responsiveness to stimula-
tion with mAb to Vs6 and other TCR epitopes (Table 3) .
The lymph node cells from tolerant animals were indeed
hyporesponsive to antiVs6 but were normally responsive to
anti-CD3 and Vs8 .
To compare other types of bone marrow-derived thymic
APC withB cells, we injected thymic dendritic cells or mac-
rophages into neonatal thymi (Fig. 4 B) . Only the dendritic
cells tolerized the mice, and as in the case of spleen dendritic
cells, Vs6 cells were not deleted . It is important to recall
that to obtain thymic dendritic cells and macrophages, it is
necessary to use collagenase-digested thymi (23), whereas
thymicB cell isolates are obtained from teased thymi and have
few other types of APC (16) .
Direct Effect of Thymic B Cells on the Deletion ofV#6+ T
Cells in Association withMHC Antigen. Deletion of Vs6+
T cells in the thymus is known to require the expression of
MHC class II I-E molecules (14, 29, 30) . To examine the
possibility that elimination of Vs6+ T cells by thymic
CD5+ B cells was due to the transfer of the Mls product
to host thymic dendritic cells, we injected thymic B cells or
Dendritic cell
Groups of four to seven neonatal mice were given an intrathymic injection of 5 x 105 APC per lobe . Responsiveness of the thymocytes to Mls-1'
and MHC antigens at 1 wk after injection was measured by lymph node swelling in local GVHR. All the data are given in terms of percent of
the positive control value using thymoctyes from uninjected mice . The values of lymph node weight in five mice as positive and negative controls
were 2.98 ± 0.18 and 0.97 ± 0.15 mg in BALB/c mice, 3 .12 ± 0.23 and 1.06 ± 0.12 mg in CxD2 mice, 3 .03 ± 0.18 and 0.89 ± 0.17 mg
in B6xD2 mice and 3.48 ± 0.31 and 1.23 *- 0.14mg in AKR mice (Exp . 1); and 3.02 ± 0.18 and0.99 ± 0.12mg in C57BL/6 mice, 2.88 ± 0.21
and 0.89 ± 0.20 mg in CxD2 mice, 3.21 ± 0.25 and 0.96 ± 0.21 mg in B6xD2 mice, and 3.54 ± 0.33 and 1.25 *_ 0.24 mg in C3H mice (Exp .
2 A) ; and 3.03 t 0.22 and 1.12 t 0.23 mg in BALB/c mice, 2.99 ± 0.27 and 1.09 ± 0.24 mg in B6xD2 mice, and 3.56 ± 0.37 and 1.26 ± 0.28
mg in AKR mice (Exp. 2 B) . Expression of Vp6 and Vg8 was monitored in a part of the bulk population of thymocytes (Exp . 2) or lymph node
cells (mixture of axillary, inguinal, brachial, and mesenteric nodes) (Exp . 1) from each mouse .
spleen dendritic cells into thymi of either I-E' or I-E+, Mls-
1a - , MHC-disparate mice (Table 4) . Although both I-E+,
Mls-1a+ thymic B cells and dendritic cells induced tolerance
to Mls-1a, only thymic B cells deleted Vs6+ T cells in
lymph nodes and thymi, even when injected into I-E - mice.
The same result was obtained by injecting activated B blasts
(not shown), i.e., Mls-la, I-E+ B blasts deleted Vs6+ T cells
in I-E - mice. These results demonstrate that Mls-expressing
thymic B cells are able to delete developing Vs6+ T cells
without the aid of I-E products on host APC .
Ontogeny of Thymic CD5+ B Cells and Mls-reactive T Cells
in Thymi . To assess ifCD5+ B cells might delete Mls-1a-
reactive T cells during normal thymus development, we moni-
tored the numbers ofVs6+ T cells and CD5+ B cells during
the first week of life in Mls-1a mice, since it is known that
Vs6+ cells appear transiently (31) . In fact, the numbers of
CD5+ B cells began to increase just at the time the Vs6+
cells began to decrease or be deleted (Fig . 5) . In a separate
experiment, we obtained the followingdata by teasing a thymic
lobe ; 1.3-1.5 x 107 cells from a 1-d-old CxD2 mouse, 3.3-
4.5 x 107 cells from a 3-d-old mouse, and 1.1-1.4 x 10 8
cells from a 7-d-old mouse, in which the numbers of thymic
B cells were 4-6 x 104 , 3.2-3.6 x 10 5 , and 1.05-1.55 x
106 , respectively . Similar numbers of total thymocytes and
thymic B cells were also obtained in BALB/c mice (data not
shown) .
The thymocytes from 4-d-oldCxD2 mice already showed
a 65-90% reduced response to Mls-la antigen, when as-
sessed by local GVHR. Almost no reactivity to Mls-la was
detected in thymocytes at day 7, as in the case ofadult CxD2
mice (not shown) .
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Exp .
Local VH reaction from thym
No . BALB/c B6xD2 C3H Vs6 V08
injected into : thymocytes of-
Surface
cytes expression in
1 18.7 24 .3 104.6 7.1 11.9
2 22.5 19.7 96.8 6.4 10.8
3 8 .2 11 .3 99.4 6.9 12.7
4 11 .5 12.0 114.7 5.4 12.1
5 9 .2 5 .6 112.0 6.0 10.9
6 2 .3 6 .6 88 .5 6.8 11.2
7 7 .4 9 .3 125 .1 7.1 11.6V
C
d
Q '
L
BALB/c CxD2
iov. ov
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on
Fluorescence intensity (Vp6)
Figure 6 .
￿
Similar decreasing pattern of V,96high-and V061--expressing
T cells in the thymus ofearly postnatalCxD2 mouse andnew born BALB/c
mouse injected with graded dose of thymic B cells. Expression of V06
was monitored in anewborn BALB/c mouse given intrathymic injection
of5 x 104 (B), 1.5 x 105 (C) or 5 x 105 thymicB cells (D), and a CxD2
mouse at age of 2 d (F), 4 d (G), 7 d (H), 14 d (I), and7 wk (J) . Age-
matched uninjected (A) and adult (E) BALB/c served as controls.
We next compared the appearance of Vs6wgb and Vp610W
T cells between CxD2 at various ages and BALB/c injected
with graded dose of thymic B cells (Fig. 6). A low dose of
thymic B cells induced a slight reduction of V#6b'ge, but not
V#6 1°-, T cells (Fig . 6 B) . A medium dose ofB cells con-
siderably deleted not only V#6b'g6 but also V#6 1- T cells
(Fig. 6 C) . On the other hand, the percentages of Vg6b'g6
and V#61ow T cells in CxD2 at 7 d were less than those in
age-matched BALB/c (Fig. 6,H vs. A), and both decreased
gradually with age (Fig . 6,G-J) . Finally, only a smallnumber
ofV061°WT cells remained in the thymus in the adult mouse
(Fig. 6,J vs . E) .
Discussion
It has been demonstrated by Mazinger and Guerder (32)
that dendritic cells from spleen abrogate the generation of
cytotoxic T cells in fetal thymus in vitro, indicating that the
dendritic cells, the most potent activator for peripheral T cells,
are also potent in the inactivation of developing T cells. The
experiments presented here examine a wider range ofAPC
and provide evidence that different types of thymic APC can
have different roles in the establishment of tolerance : thymic
B cells tolerize by a deletion mechanism ; thymic dendritic
cells tolerize by inducing anergy ; and thymic macrophages
are inactive. Deletion also was observed with splenicB blasts
but not resting B cells . Like thymic dendritic cells, spleen
dendritic cells induce anergy, while splenic macrophages are
inactive .
Mls, which has not been identified biochemically, is a cell-
associated antigen that is expressed gradually onB cells (17-19) .
Dendritic cells did not express detectable Mls previously (17,
18), whereas our results here show that both thymic and splenic
dendritic cells can express Mls-1', as reported by Sunshine
et al . (33) . Mls-13-specific T cell proliferation induced by
dendritic cells is not due to B cells that contaminate the den-
dritic cell preparation, since B cell depletion did not affect
the stimulatory activity ofdendritic cells, and highly purified
N418+ dendritic cells also induced T cell proliferation to
Mls-1'. This discrepancy may be ascribed to the difference
of mouse strains or to the method of assay. In our case,
we used CxD2 mice and monitored V#6+, Mls-1'-reactive
blasts directly.
Hengartner et al . (34) have documented that T cells bearing
TCR with self-reactivity are present at high density in the
thymic cortex but not in the medullary region . This
strengthens the idea that the deletion of self-reactive T cells
takes place at the cortico-medullary junction, where bone
marrow-derived dendritic cells are localized (35, 36) . How-
ever, our results show that dendritic cells injected intrathymi-
cally do not induce deletion of self-reactiveT cell clones. Con-
sidering that thymic B cells are detected throughout the
thymus (37) and that Mls antigens are a product of activated
B cells (17, 18), it may well be that the dendritic cell only
acquires small amounts of Mls antigens during their prepa-
ration as a result of transfer from thymic B cells or spleen
B cells (14) . This idea seems to be compatible with the result
that fresh N418+ thymic and spleen dendritic cells are
equally potent in stimulating MHC-incompatible T cells, but
thymic dendritic cells aremuch less effective in inducing Mls-
disparate T cell proliferation than spleen dendritic cells . Larger
amounts ofMls antigens on dendritic cells, which might be
produced by injected thymic B cells, may lead to deletion
rather than anergy. This possibility remains to be elucidated .
The mechanism of clonal deletion by thymic B cells or
splenic B blasts injected intrathymically is so far not clear.
The APC might directly interact with developingT cells in
cortex or medulla. Both dendritic cells and B cells in thethymus are detected at 14 d of gestation (38-42) . B cells in-
crease in number after birth by day 7 . Preceding this, the
number ofVs6+ T cells in the CxD2 mouse reaches a max-
imum at day 3-4 and then decreases. These results seem to
support the idea that Mls products secreted by thymicB cells
are taken up by dendritic cells, and then, Mls-reactiveT cells
are clonally deleted . It has been documented that tolerance
to Mls results from the selective depletion of Vs6high T cells
(34), and that the class II I-E molecules are required for the
presentation of the Mls-1' product to V06-expressing T cells
in the thymus (29, 30) . However, thymic B cell-induced toler-
ance was accompanied by the deletion of not only Vs6high
but also V06 10-expressing T cells . A similar phenomenon
was observed even when thymic B cells were injected into
Mls-1' - , I-E - C57BL/6 mice. In addition, a low dose of
thymicB cell induced the incomplete but preferential decrease
of Vs6high T cells, whereas a medium dose significantly re-
duced both Vo6high and Vo6l°"' cells. This was also the case
when CxD2 thymic B cells were injected into neonatal
C57BL/6 thymi (data not shown) . Therefore, our conclu-
sion for the time being is that thymic B cells by themselves
can, after intrathymic injections, directly interact with de-
veloping V,361°"'-positive T cells and delete them .
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Recently, Webb and Sprent (43) reported that CD8+ T
cells play a role in the clonal deletion of Mls-reactiveT cells
in the thymus . They inoculated the cells into newborn mice
intravenously via the facial vein . Small numbers of injected
cells migrated into the thymus, and the tolerant state lasted
for >7 wk . We cannot exclude the possibility that small
numbers of CD8+ T cells contaminate our preparation of
dendritic cells or thymic B cells. Unlike their report, how-
ever, thymic dendritic cells or B cells injected intrathymically
induced temporary tolerance that lasted only 9-10 d and was
not detectable at 14 d both in the thymus and in lymph nodes
(data not shown) . Therefore, dendritic cells andB cells, which
express the class IIMHC molecules needed to present Mls,
may differ in the mechanism of tolerance induction from
CD8+ T cells that do not express class II .
The direct, neonatal intrathymic injection protocol described
heremay prove useful in delineating the role of specific types
ofAPC in the induction of self-tolerance . A role of thymic
B cells, including CD5+ B cells, might be considered in fur-
ther analyses of this important area of thymus physiology.
Our results apply to the widely studied Mls-1° antigen, and
need to be extended to other antigens.
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